A pH-responsive polymer gel could create swallowable devices, including capsules for ultra-long drug delivery
Medical devices designed to reside in the stomach have a variety of applications, including prolonged drug delivery, electronic monitoring, and weight-loss intervention. However, these devices, often created with nondegradable elastic polymers, bear an inherent risk of intestinal obstruction as a result of accidental fracture or migration. As such, they are usually designed to remain in the stomach for a limited time.
Now, researchers at MIT’s Koch Institute for Integrative Cancer Research and Massachusetts General Hospital (MGH) have created a polymer gel that overcomes this safety concern and could allow for the development of long-acting devices that reside in the stomach, including orally delivered capsules that can release drugs over a number of days, weeks, or potentially months following a single administration.
This polymer is pH-responsive: It is stable in the acidic stomach environment but dissolves in the small intestine’s near-neutral pH, allowing for safe passage through the remainder of the gastrointestinal (GI) tract. The material is also elastic, allowing for the compression and folding of devices into easily ingestible capsules — meaning this polymer can be used to create safe devices designed for extremely prolonged residence in the stomach.
“One of the issues with any device in the GI tract is that there’s the potential for an obstruction, which is a medical emergency potentially requiring surgical intervention,” says Koch Institute research affiliate Giovanni Traverso, also a gastroenterologist at MGH and an instructor at Harvard Medical School. “A material like this represents a real advance because it is both safe and stable in the stomach environment.”
Traverso and Robert Langer, the David H. Koch Institute Professor at MIT and a member of the Koch Institute, are the senior authors of a paper in the July 27 issue of Nature Materials that describes the application of this new polymer gel for creating gastric devices. Shiyi Zhang, a postdoc at the Koch Institute, is the paper’s lead author.
Designing devices for the stomach is a complicated matter of sizes and shapes. The stomach naturally empties its contents in a matter of hours, so for devices to be retained, they must be wider than the pylorus — the valve at the end of the stomach, about 1.5 to 2 centimeters in diameter, that allows gastric contents to pass into the small intestine. However, because the most convenient path to deliver these devices is through the esophagus, which is only marginally wider than the pylorus, the researchers were interested in developing a polymer with elastic properties.
“An elastic device can be folded into something small, such as a capsule, and be easily ingested through the esophagus before expanding in the stomach, restoring its original shape,” Zhang says. “When you have a device that’s larger than the pylorus, there’s a much higher probability that it will be retained longer in the stomach.”
But the size and shape of existing devices with elastic polymers have been limited by safety concerns, as there is a greater risk for fracture if a device is too large or too complex. Because of this, the researchers wanted their polymer to also be enteric — or have a mechanism that would enable it to pass through the stomach unaltered before disintegrating in the intestines.
“To lower any possible risk of obstruction, we wanted a material that could dissolve in the intestines, thereby dissociating the device, and safely pass out of the body,” Zhang says.
To create this new material, the researchers synthesized an elastic polymer and combined it in solution with a clinically utilized enteric polymer. Adding hydrochloric acid and centrifuging the solution resulted in a flexible, yet resilient, polymer gel that exhibits both elastic and enteric properties.
The researchers used the gel polycaprolactone (PCL), a nontoxic, degradable polyester, to construct several device prototypes. They first created ring-shaped devices by using the gel to link arcs of PCL in a circular mold. These elastic devices had a diameter of 3 centimeters — wider than the pylorus — before they were folded into orally ingestible capsules.
In testing the capsules in pigs, the researchers found that the rings expanded into their original shape within 15 minutes of ingestion and remained in the stomach for up to seven days. After the device passed out of the stomach, the polymer gel dissolved, allowing for the safe passage of the small PCL pieces without obstruction. The researchers also created larger devices in various shapes that could be folded and delivered through the esophagus with the assistance of an endoscope. These devices remained in the stomach for up to five days, after which the gel similarly dissolved, allowing for the remnants of the device to safely pass.
The Latest on: Long-acting pills
via Google News
The Latest on: Long-acting pills
- Male Birth Control Is Coming—But I Don’t Plan on Giving Up Mineon August 15, 2019 at 5:26 pm
Methods of preventing pregnancy have been around for centuries, but it wasn’t until hormonal contraceptives like the pill and long-acting reversible contraceptives (LARCs), such as IUDs and implants, ...
- Dupixent drives Sanofi again, but other new drugs are laggingon August 14, 2019 at 8:51 pm
Genzyme posted a 22% increase in revenues to €2,29bn, and while a lot of that was down to Dupixent there was also a 9% increase for its rare disease drugs. There was bad news for Genzyme’s blood ...
- Anesthetics Market : Growth, Demand and Key Players to 2028on August 9, 2019 at 9:00 am
Rockville, MD -- (SBWIRE) -- 08/09/2019 -- Long acting anesthetics drugs are used to induces anesthesia. Long acting anesthetics drugs are effective for both postoperative and intraoperative surgeries ...
- AARP seeks public's help in campaign to lower drug priceson August 8, 2019 at 7:16 pm
Nearly a quarter of Americans take prescription drugs. Seniors use an average of four to five ... "I take one injection a day, which is long acting and stays with me all day, which is another very ...
- Global Asthma and COPD Drugs Market With Global Business Opportunities Assessment With Revenue, Price And Gross Margin Analysis 2025on August 8, 2019 at 12:39 am
Long Acting Beta Agonists (LABA) Others The study objectives of this report are: To analyze and study the global Asthma and COPD Drugs capacity, production, value, consumption, status (2013-2017) and ...
- Editorial: Americans deserve affordable, safe prescription drugson August 7, 2019 at 11:21 pm
A 20-milliliter vial of long-acting Humulin R that was $175.57 is now $1,487. A typical vial that will last a diabetic about 10 days costs about $300 in the United States, while in Canada it’s just ...
- Lyndra Therapeutics to Develop Once-Monthly Oral Contraceptiveon August 6, 2019 at 1:49 am
Taking a single, long-acting pill weekly instead of daily or more often can improve medication adherence and health outcomes while reducing burdens on individuals and their caregivers. Inside a ...
- How Long-acting Family Planning Method Brings Peace Of Mindon July 26, 2019 at 10:25 pm
Long-acting Reversible Contraceptives ... an unplanned pregnancy after she utterly forgot using her contraceptive pills as prescribed due to her busy schedule at work, had intercourse with ...
- Multiple dosing of long-acting rilpivirine in a model of HIV pre-exposure prophylaxison July 25, 2019 at 12:36 pm
PrEP works if properly taken. Long-acting formulations can eliminate problems when high risk individuals forget to take their pills every day. The development of successful long-acting PrEP ...
- Revamped OxyContin was supposed to reduce abuse, but has it?on July 22, 2019 at 10:52 am
THE CONTINUING COST OF OXYCONTIN First launched in 1996, the original OxyContin helped spark a wave of abuse as some people quickly learned to crush the long-acting pills to release a massive opioid ...
via Bing News